In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis

Clinical and Experimental Immunology

Volumn 166, Issue 1, 2011, Pages 87-93

  Tercelj M ^a   Stopinsek S ^b   Ihan, A ^b   Salobir, B ^a   Simcic S ^b   Wraber, B ^a   Rylander, R ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Biofact Environmental Health Research Center   (Sweden)

Author keywords

glucan; Chitin; Endotoxin; Fungi; Sarcoidosis

Indexed keywords

BETA GLUCAN; BETA N ACETYLHEXOSAMINIDASE; CHITIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; EXPOSURE; FEMALE; FUNGAL CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUNG SARCOIDOSIS; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY;

AIR POLLUTANTS; BETA-GLUCANS; BIOLOGICAL MARKERS; CELL WALL; CHITIN; CYTOKINES; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGI; HEXOSAMINIDASES; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 80052608080     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04456.x     Document Type: Article

References (31)

1. Hill TA, Lightman S, Pantelidis P, Abdallah A, Spagnolo P, du Bois RM. Intracellular cytokine profiles and T cell activation in pulmonary sarcoidosis. Cytokine 2008; 42:289-92.
2. Zissel G, Prasse A, Müller-Querheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med 2010; 31:390-403.
3. Gerke A, Hunnunghake G. The immunology of sarcoidosis. Clin Chest Med 2008; 29:379-90.
4. S-i N, Miyazaki E, Ando M etal. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis. Respir Med 2008; 102:239-47.
5. Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. J Physiol Pharmacol 2008; 59 (Suppl. 6):507-13.
6. Hata M, Sugisaki K, Miyazaki E, Kumamoto T, Tsuda T. Circulating IL-12p40 is increased in patients with sarcoidosis; correlation with clinical markers. Intern Med 2007; 46:1387-93.
7. Moller DR, Forman JD, Liu MC etal. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156:4952-60.
8. Newman LS, Rose CS, Bresnitz EA, the ACCESS Research Group. A case-control etiological study of sarcoidosis - environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170:1324-30.
9. Laney AS, Cragin LA, Blevins LZ etal. Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air 2009; 19:83-90.
10. Terčelj M, Salobir B, Rylander R. Airborne enzyme in homes of patients with sarcoidosis. Env Health 2011; 10:8-13.
11. Terčelj M, Rott T, Rylander R. Antifungal treatment in sarcoidosis - a pilot intervention trial. Resp Med 2007; 101:774-8.
12. Terčelj M, Salobir B, Rylander R. Antifungal medication is efficient in treatment of sarcoidosis. Ther Adv Resp Dis 2011; 5:157-62.
13. Terčelj M, Salobir B, Rylander R. Microbial antigen treatment in sarcoidosis - a new paradigm? Med Hypotheses 2008; 70:831-4.
14. Rylander R. Organic dust induced pulmonary disease - the role of mould derived β-glucan. Ann Agric Environ Med 2010; 17:9-13.
15. Mazzarelli RAA. Chitins and chitosans as immunoadjuvants and non-allergic drug carriers. Mar Drugs 2010; 8:292-312.
16. Yoon HJ, Moon ME, Park HS, Im SY, Kim YH. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 2007; 358:954-59.
17. Stopinšek S, Ihan A, Wraber B etal. Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. Int Immunopharmacol 2011; 8:939-47.
18. Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999; 160:736-55.
19. Terčelj M, Salobir B, Wraber B, Simcic S, Rylander R. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases. Scand J Clin Lab Invest 2009; 69:575-8.
20. Smit LAM, Heederik D, Doekes G, Krop EJM, Rijkers GT, Wouters IM. Ex vivo cytokine release reflects sensitivity to occupational endotoxin exposure. Eur J Respir Dis 2009; 34:795-802.
21. Rylander R, Reeslev M, Hulander T. Airborne enzyme measurements to detect indoor mould exposure. J Environ Monit 2010; 12:2161-4.
22. Rylander R, Jacobs RR. Endotoxins in the environment: a criteria document. Int J Occup Environ Health 1997; 3:S1-48.
23. Young S-H, Robinson VA, Barger M etal. Exposure to particulate 1-3-β-glucans induces greater pulmonary toxicity than soluble 1-3-β-glucans in rats. J Toxicol Environ Health A 2003; 66:25-38.
24. Rylander R, Fogelmark B, Ewaldsson B. Mouldy environments and toxic pneumonitis. J Toxicol Ind Health 2008; 24:177-80.
25. Holt PG, Batty JE. Alveolar macrophages V: comparative studies on the antigen presentation activity of guinea pig and rat alveolar macrophages. Immunology 1980; 14:361-6.
26. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-81.
27. Oltmanns O, Schmidt B, Hoerning S, Witt C, John M. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. Exp Lung Res 2003; 29:315-28.
28. Bingisser R, Peich R, Zollinger A, Russi E, Frei K. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration 2000; 67:280-6.
29. Herfarht HH, Mohanty SP, Rath HC, Tonkonogy S, Sartor RB. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996; 39:836-45.
30. Inoue K, Takano H, Oda T etal. Candida soluble cell wall β-D-glucan induces lung inflammation in mice. Int J Immunopath Pharmacol 2007; 20:499-508.
31. Kokturk N, Han ER, Turktas H. Atopic status in patients with sarcoidosis. Allergy Asthma Proc 2005; 26:121-4.